← SynDRA
NSC-23766
SynDRA canonical compound SYN0079251 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Mechanism of action | Ras GTPase inhibitor |
|---|
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABL1
- PAK1
- MKNK2
- MST1R
- NEK2
- NEK4
- NTRK1
- NTRK2
- NTRK3
- PAK4
- MET
- PBK
- PDGFRA
- PDGFRB
- PDPK1
- PHKG2
- PIM1
- PIM2
- MINK1
- MELK
- PKN2
- MAPK13
- MAP3K20
- MAP4K2
- MAP4K4
- MAP4K5
- MAPK1
- MAPK10
- MAPK12
- MAPK14
- MATK
- MAPK8
- MAPK9
- MAPKAPK2
- MAPKAPK3
- MAPKAPK5
- MARK3
- MARK4
- PIM3
- PLK1
Cross-references
Synonyms
- Nsc 23766
- NSC 23766 (hydrochloride)
- NSC23766
- RGM7SKV2JS
- MFCD08703096
- UNII-RGM7SKV2JS
- NSC-23766 free base
- NSC-23766 free base?
- orb1690302
- SCHEMBL2639296
- CHEBI:91883
- GTPL11057
- CHEBI:144984
- DEFBCZWQLILOJF-UHFFFAOYSA-N
- HMS3742G11
- C24H35N7
- EX-A2403
- AKOS032945734
- NSC 23766 TETRAHYDROCHLORIDE
- CS-3234
- SB19475
- SMP2_000232
- NCGC00092318-02
- NCGC00092318-04
- NCGC00092318-11
- AC-35879
- DA-76299
- HY-15723
- LS-15068
- N7210
- G60946
- T40848
- BRD-A80213327-305-01-8
- BRD-A80213327-305-07-5
- BRD-A80213327-305-08-3
- BRD-A80213327-305-11-7
- N6-[2-[5-(diethylamino)pentan-2-ylamino]-6-methyl-4-pyrimidinyl]-2-methylquinoline-4,6-diamine
- BN162673
- DTXCID801021625
Look up NSC-23766 in the interactive SynDRA portal →